Editors’ Picks, March 2025: Cancer Cell Senescence, Ultraviolet Protection, and More
This month, the editors of AACR's journals tout studies showcasing the immunostimulatory impact of senescent cancer cells, a novel...
Tag: Bladder cancer
This month, the editors of AACR's journals tout studies showcasing the immunostimulatory impact of senescent cancer cells, a novel...
Clinical trials for dogs with cancer can extend the lives of our four-legged friends while revealing insights about cancer...
At a recent AACR Special Conference, experts discussed emerging therapeutic options to overcome resistance to Bacillus Calmette-Guérin (BCG).
Dan Theodorescu and Lars Dyrskjøt preview the AACR's upcoming conference on bladder cancer.
Bladder cancer is a common malignancy originating in the bladder, a hollow organ located in the abdomen that stores urine. It is the sixth most prevalent cancer in the United...
During late March and early April, the U.S. Food and Drug Administration (FDA) made several decisions that have increased...
This time last year there were no immune checkpoint inhibitors approved by the U.S. Food and Drug Administration (FDA)...
Earlier this week, the U.S. Food and Drug Administration (FDA) announced that it had approved a new immune checkpoint...
Last week, the U.S. Food and Drug Administration (FDA) announced that it had approved expanding the use of the...
Last week, the U.S. Food and Drug Administration (FDA) increased the number of cancer types for which immunotherapeutics known...